Table 2.
Measure | MI (n = 55) | FO(n = 41) | Post hoc tests within 6-month timeframe |
Effect Size | ||
Mean (SD) | Mean (SD) | df | F (time) | F (Time × Tx) | ||
No. days used marijuana past 30 days | ||||||
Baseline | 15.83 (11.60) | 11.78 (11.37) | ||||
6-month follow-up | 12.24 (11.75) | 8.71 (10.88) | 1/94 | 8.46** | 0.05 | .31 (MI) |
.28 (FO) | ||||||
12-month follow-up | 9.37 (10.97) | 9.91 (11.59) | 1/94 | 0.80 | 4.72* | .57(MI) |
.16 (FO) | ||||||
MI (n = 25) | FO (n = 33) | |||||
Mean (SD) |
Mean (SD) |
|||||
No. days used marijuana with alcohol past 30 days | ||||||
Baseline | 6.48 (6.58) | 4.15 (4.77) | ||||
6-month follow-up, with 6-month alcohol use controlled | 2.92 (3.40) | 6.36 (6.98) | 1/56 | 0.65 | 11.92‡ | .54 (MI) |
1/56 | 12.43† | 2.07 | −.46 (FO) | |||
12-month follow-up | 3.13 (4.23) | 4.29 (5.82) | 1/56 | 0.19 | 0.67 | .51 (MI) |
−.03 (FO) |
Notes: Sample size for analyses are participants for which follow-up data were available (attrition 19% at 12 months with no significant differences by treatment condition; Monti et al., 2007). MI = motivational interviewing with personalized feedback; FO = personalized feedback only; Tx = treatment.
p < .05
p < .01
p < .005
p < .001.